Sierra Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SRRA and buy or sell other stocks, ETFs, and their options commission-free!About SRRA
Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to identify compounds that target the root cause of disease.
CEOStephen George Dilly, PhD
CEOStephen George Dilly, PhD
Employees—
Employees—
HeadquartersSan Mateo, California
HeadquartersSan Mateo, California
Founded2003
Founded2003
Employees—
Employees—
SRRA Key Statistics
Market cap1.34B
Market cap1.34B
Price-Earnings ratio-8.13
Price-Earnings ratio-8.13
Dividend yield—
Dividend yield—
Average volume583.08K
Average volume583.08K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$55.19
52 Week high$55.19
52 Week low$14.91
52 Week low$14.91
Stock Snapshot
The current Sierra Oncology(SRRA) stock price is $54.99, with a market capitalization of 1.34B. The stock trades at a price-to-earnings (P/E) ratio of -8.13.
On 2026-03-12, Sierra Oncology(SRRA) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Sierra Oncology(SRRA) stock has reached 0, versus its average volume of 583.08K.
Over the past 52 weeks, Sierra Oncology(SRRA) stock has traded between a high of $55.19 and a low of $14.91.
Over the past 52 weeks, Sierra Oncology(SRRA) stock has traded between a high of $55.19 and a low of $14.91.
People also own
Based on the portfolios of people who own SRRA. This list is generated using Robinhood data, and it’s not a recommendation.